Laughing Water Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the ...

In a challenging turn of events for Ocean Biomedical, the company's stock has tumbled to a 52-week low, reaching a price ...

Lifecore Biomedical, Inc. announced plans to hold a special stockholders meeting on April 10, 2025, to seek approval for a proposal related to its Series A Convertible Preferred Stock. The ...

Lifecore’s board of directors has approved that holders of record of Lifecore’s Common Stock and Convertible Preferred Stock as of the close of business on February 18, 2025 (the “Record Date”), will ...

Learn more about a recompete NIH contract awarded to the Alliance for Advancing Biomedical Research to operate NCI's ...

Jan. 07, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has ...

A Providence law firm wants to cut ties with Ocean Biomedical, the once-celebrated Brown University startup that now faces a web of legal and financial troubles.

WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its product platform is ...

CHASKA, Minn., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing ...